WASHINGTON, Oct 2 (Reuters) - U.S. regulators have warned Genzyme Corp (GENZ.O: Quote, Profile, Research) about manufacturing problems at a French plant where the company makes a product for transplant patients, a letter released on Tuesday said.
WASHINGTON, Oct 2 (Reuters) - U.S. regulators have warned Genzyme Corp (GENZ.O: Quote, Profile, Research) about manufacturing problems at a French plant where the company makes a product for transplant patients, a letter released on Tuesday said.
